For example, in a study comparing participants with T2DM who were receiving multiple daily injections of insulin either trained on a new meter (Abbott Freestyle Lite) or using flash glucose monitoring (Abbott Libre), HbA1c reductions of 0.31% and 0.29%, respectively, were observed after 24 weeks from a baseline HbA1c of 8.8% [18]. The gene discussed is INS; the disease is type 2 diabetes mellitus.